Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D
China-based Consun Pharmaceutical Group Ltd (HKG: 1681) announced a strategic partnership with compatriot firm DP...
HKG: 1681
Consun Pharmaceutical Gets NMPA Go-Ahead for CKD Drug Clinical Trial
Consun Pharmaceutical Group Ltd (HKG: 1681), a leading Chinese pharmaceutical company, has announced that it...
Wanbangde Pharmaceutical to Acquire Consun Pharma Shares in RMB 2.2B Deal
China-based Wanbangde Pharmaceutical Group has entered into a non-legally binding letter of intent with Consun...